Nyxoah S.A.NYXH

$1.60+0.01 (+0.63%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$69M

Micro-cap

-75%

2021 — today

10-Year Price

-87%

2021 — today

52-Week Range

$1.31$8.28

Current $1.60· 4%

Nyxoah S.A. is a medical technology company dedicated to developing and bringing to market therapies for sleep disordered breathing conditions. Its flagship offering is the Genio system, a CE-Marked, patient-focused hypoglossal neurostimulation therapy that addresses moderate to severe obstructive sleep apnea. Established in 2009, the company maintains its headquarters in Mont-Saint-Guibert, Belgium.

Valuation in context

P/E ratio

-0.7

N/A

Not meaningful — company is unprofitable

P/B ratio

1.9

Below average

Below the 10-year average

FCF Yield

-106.0%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when NYXH is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.